Abstract:Systemic lupus erythematosus (SLE; OMIM 152700) is an important disorder of autoimmunity characterized by the presence of antibodies to nuclear self-antigens and the involvement of multiple organs. The etiopathogenesis of SLE is complex and is still largely unknown. Both genetic and environmental factors contribute to disease susceptibility (Kyogoku and Tsuchiya, 2007Kyogoku C. Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway.Genes Immun. 2007; 8: 445-455Crossref PubMed Scopus (76) Google Scholar). The prevalence of SLE and its manifestations varies among different ethnic and geographical populations (Lau et al., 2006Lau C.S. Yin G. Mok M.Y. Ethnic and geographical differences in systemic lupus erythematosus: an overview.Lupus. 2006; 15: 715-719Crossref PubMed Scopus (173) Google Scholar), with higher prevalence rates and more severe complications in non-European populations. For example, higher rates of lupus nephritis have been observed in Asians, Hispanics, and African Americans (Johnson et al., 1995Johnson A.E. Gordon C. Palmer R.G. et al.The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth.Arthritis Rheum. 1995; 38: 551-558Crossref PubMed Scopus (314) Google Scholar; Seligman et al., 2002Seligman V.A. Lum R.F. Olson J.L. et al.Demographic differences in the development of lupus nephritis: a retrospective analysis.Am J Med. 2002; 112: 726-729Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar). In contrast, higher prevalence rates of photosensitivity have been noted in Europeans (Ward and Studenski, 1990Ward M.M. Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences.Arch Int Med. 1990; 150: 849-853Crossref PubMed Google Scholar). Genetic heterogeneity of SLE may underlie these ethnic differences in SLE manifestations. Despite considerable clinical heterogeneity, SLE is one of the most heritable autoimmune diseases, with a sibling risk ratio of ∼30 (Vyse and Todd, 1996Vyse T.J. Todd J.A. Genetic analysis of autoimmune disease.Cell. 1996; 85: 311-318Abstract Full Text Full Text PDF PubMed Scopus (632) Google Scholar). Increased understanding of the genetic basis for SLE is of key importance in improving the prognosis of patients with SLE. Recent genome-wide association studies (GWAS) and candidate gene studies have confirmed genetic associations of over 40 loci with SLE risk that achieve genome-wide significance (P<5 × 10-8), with some of these susceptibility loci validated independently in different populations (Cui et al., 2013Cui Y. Sheng Y. Zhang X. Genetic susceptibility to SLE: recent progress from GWAS.J Autoimmun. 2013; 41: 25-33Crossref PubMed Scopus (165) Google Scholar). Most of these associated gene products participate in key pathogenic pathways involved in the development of SLE, such as Toll-like receptor signaling, immune complex processing, and type I interferon production. The GWAS approach has been extremely successful in pinpointing the association of common genetic variants with diseases or disease-related quantitative phenotypes. However, given the small sizes of the expected effect in a polygenic model, individual GWAS are generally too small to provide the necessary power to detect single-nucleotide polymorphism (SNP) associations while accounting for the multiple number of independent tests. Therefore, the genetics community has widely adopted the approach of combining summary statistics from multiple GWAS into a single meta-analysis to increase the statistical power of the analysis by augmenting the effective sample size. For example, we performed meta-analysis of two existing GWASs on Chinese Han populations and followed the findings by further replication in several additional Asian cohorts, and identified genetic variants in or near five genes as associated with SLE: CDKN1B, TET3, CD80, DRAM1, and ARID5B (Yang et al., 2013Yang W. Tang H. Zhang Y. et al.Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians.Am J Hum Genet. 2013; 92: 41-51Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). In addition, we discovered multiple independent susceptibility variants for the disease in the 11q23.3 region (Zhang et al., 2014Zhang J. Zhang Y. Yang J. et al.Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians.Hum Mol Genet. 2014; 23: 524-533Crossref PubMed Scopus (26) Google Scholar). To determine the association with both SNPs and classical human leukocyte antigen (HLA) alleles for SLE, Morris et al., 2012Morris D.L. Taylor K.E. Fernando M.M. et al.Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans.Am J Hum Genet. 2012; 91: 778-793Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar performed a meta-analysis of the MHC region from six studies and well-known out-of-study control data sets. They found the best model for SLE association includes both classical loci (HLA-DRB1(*)03:01, HLA-DRB1(*)08:01, and HLA-DQA1(*)01:02) and two SNPs, rs8192591 and rs2246618 (Morris et al., 2012Morris D.L. Taylor K.E. Fernando M.M. et al.Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans.Am J Hum Genet. 2012; 91: 778-793Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar). Meta-analysis of GWAS was also performed to gain insight into the common genetic basis of various autoimmune diseases. To explore candidate SNPs and candidate mechanisms of SLE and rheumatoid arthritis (RA), Lee et al., 2012Lee Y.H. Bae S.C. Choi S.J. et al.Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis.Mol Biol Rep. 2012; 39: 10627-10635Crossref PubMed Scopus (81) Google Scholar carried out meta-analysis of two SLE GWAS data sets in European and Korean individuals. In addition to the HLA region, this study identified six SNPs associated with SLE with genome-wide significance (STAT4, TNPO3, BLK, FAM167A, and IRF5), and ICSNPathway identified five candidate causal SNPs and 13 candidate causal pathways involved in different cellular functions, such as bystander B-cell activation, cytokine network, and collagen metabolic processing, which may contribute to SLE susceptibility. They also revealed candidate causal non-HLA SNPs, genes, and pathways involved in RA (Lee et al., 2012Lee Y.H. Bae S.C. Choi S.J. et al.Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis.Mol Biol Rep. 2012; 39: 10627-10635Crossref PubMed Scopus (81) Google Scholar). In order to reveal the genetic basis of systemic sclerosis (SSc) and SLE, Martin et al., 2013Martin J.E. Assassi S. Diaz-Gallo L.M. et al.A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.Hum Mol Genet. 2013; 22: 4021-4029Crossref PubMed Scopus (82) Google Scholar performed a pan-meta-analysis of two GWAS together with a replication stage. This study identified KIAA0319L as a novel susceptibility locus for SSc and SLE, and they also determined that the previously described SLE susceptibility loci PXK and JAZF1 are shared with SSc. In addition, Chung et al., 2014Chung S.A. Brown E.E. Williams A.H. et al.Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.J Am Soc Nephrol. 2014; 25: 2859-2870Crossref PubMed Scopus (89) Google Scholar completed a meta-analysis of three GWAS of SLE to investigate lupus nephritis–predisposing loci and identified multiple susceptibility variants within four non-HLA loci associated with this disorder, such as 4q11-q13 (PDGFRA and GSX2), 16p12 (SLC5A11), 6p22 (ID4), and 8q24.12 (HAS2 and SNTB1). Results from this large-scale genome-wide investigation of lupus nephritis provide evidence for multiple biologically relevant lupus nephritis susceptibility loci (Chung et al., 2014Chung S.A. Brown E.E. Williams A.H. et al.Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.J Am Soc Nephrol. 2014; 25: 2859-2870Crossref PubMed Scopus (89) Google Scholar). Meta-analysis of GWAS, aimed at increasing the power of studies by combining the results from different study populations, have led to the identification of novel associations that would not otherwise have been identified in individual GWASs. Therefore, studies employing increased sample size, meta-analysis of existing GWAS, and trans-ethnic populations are possible approaches that could uncover some of the missing susceptibility variants for SLE and move us toward a better understanding of the disease and possible intervention. Large-scale meta-analysis clearly represents a powerful tool for identifying novel genetic variants for SLE. Although meta-analysis can be very powerful, its application must be executed with caution. It is known that meta-analysis may introduce false-positive/-negative results due to heterogeneity and other confounding factors. Consequently, it is important to exert caution when designing studies, and interpreting results generated by meta-analysis of GWASs. In addition, conducting these large-scale meta-analyses requires an extensive, concerted effort in collaboration and coordination among various research centers and groups, as well as centralization and standardization of data analyses. It still needs other large-scale meta-analysis of GWASs to reveal additional genetic risk factors relevant to SLE risk. In addition, further study focused on the associated genes identified by meta-analysis of GWAS, should advance our understanding of the pathogenesis of SLE. The authors state no conflict of interest. This work was supported by grants from National Key Basic Research Program of China (2014CB541901, 2012CB722404, and 2011CB512103), the National Natural Science Foundation of China (81402590, 31000528, 81071940, 30972727, and 81171505), and Youth Science Training Program of National Natural Science Foundation of China (2010kj10).

Genome-Wide Identification of Cell Type-Specific Susceptibility Genes for SLE Through the Analysis of RNA Modification-Associated SNPs

Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus

Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus

Long Non-Coding RNAs in Systemic Lupus Erythematosus: New Insights into Disease Pathogenesis and Diagnosis.

Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis

Several Critical Cell Types, Tissues, and Pathways Are Implicated in Genome-Wide Association Studies for Systemic Lupus Erythematosus

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus

Biological Insights into Systemic Lupus Erythematosus Through an Immune Cell-Specific Transcriptome-Wide Association Study

Functional Relevance for Associations Between Genetic Variants and Systemic Lupus Erythematosus

Genome-wide identification of RNA modification-related single nucleotide polymorphisms associated with rheumatoid arthritis

Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes

A multilayered post‐GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE)

Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus

The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus at Single-Cell Resolution.

The Contribution of Meta-Analysis of Genome-Wide Association Studies in Investigating the Genetic Susceptibility to Lupus.

704 Global Identification of Lupus Genetic Risk Variants Modulating the Type I Interferon Pathway Through CRISPR-based Genomic Screening

SLE Non-Coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-Critical Microrna Expression

Mapping systemic lupus erythematosus heterogeneity at the single-cell level

Assessing the causal relationship between immune traits and systemic lupus erythematosus by bi-directional Mendelian randomization analysis

Integrative Analysis of Long Non-Coding RNAs and Messenger RNA Expression Profiles in Systemic Lupus Erythematosus.